Publication date: Available online 14 December 2018Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Kimberly A. Risma, Rebecca A. MarshAbstractHemophagocytic lymphohistiocytosis (HLH) is an overwhelming clinical syndrome associated with extreme immune activation. Familial HLH is caused by autosomal recessive inheritance of gene mutations that cripple lymphocyte cytotoxicity. X-linked lymphoproliferative diseases and mutations in NLRC4 also feature HLH as a predominant manifestation. Additionally, "secondary" HLH may occur in immunocompromised patients or in individuals with previously intact immune responses in the context of strong immunologic triggers such as Epstein Barr Virus (EBV) infection, malignancy, rheumatologic disease, and drug hypersensitivity....
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2rBeFWF
Σάββατο 15 Δεκεμβρίου 2018
Hemophagocytic Lymphohistiocytosis: Clinical presentations and diagnosis
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.